118 results
Page 4 of 6
8-K
lic7ga
26 Jan 09
Departure of Directors or Principal Officers
12:00am
425
EX-99.1
8i94cigtf9h2ac7
26 Sep 08
Business combination disclosure
12:00am
8-K
EX-99.1
o8hzk1 k2
25 Sep 08
Ligand to Acquire Pharmacopeia Webcast
12:00am
425
EX-99.1
85wyc2ygkf45c
25 Sep 08
Business combination disclosure
12:00am
425
365uug6ekt 7nq1e
25 Sep 08
Business combination disclosure
12:00am
8-K
EX-99.2
ewwaj nne
24 Sep 08
1 Joseph A. Mollica, Ph.D., Chairman of the Board, Interim President & CEO, Pharmacopeia John L. Higgins, President & CEO
12:00am
425
EX-99.2
jxht2udz5m9bxvzbi
24 Sep 08
Business combination disclosure
12:00am
424B3
84e9md2md o65lq7lctz
4 May 07
Prospectus supplement
12:00am
8-K
EX-10
aw46pqm qkbrb0dgf
4 May 07
Termination of a Material Definitive Agreement
12:00am
8-K
EX-99.1
zbn 17b7d
6 Feb 07
Ligand Announces Corporate Restructuring
12:00am
424B3
h4ah60nd
6 Feb 07
Prospectus supplement
12:00am
DEFM14A
cs8vyig6q3x8
24 Jan 07
Proxy related to merger
12:00am
424B3
getagnoon4k7
16 Jan 07
Prospectus supplement
12:00am
PRER14A
0gsadevuhuz2
14 Dec 06
Preliminary revised proxy
12:00am
CORRESP
8v38 8avftz
14 Dec 06
Correspondence with SEC
12:00am
PREM14A
c4a0hv9h
6 Nov 06
Preliminary proxy related to merger
12:00am
8-K
EX-99
7ib2hqpx70yw6x
11 Sep 06
Regulation FD Disclosure
12:00am
424B3
ma5nt5yt2a m7u7zfx4f
15 May 06
Prospectus supplement
12:00am